The MEC1 and MEC2 Lines Represent Two CLL Subclones in Different Stages of Progression towards Prolymphocytic Leukemia

• Eahsan Rasul ,

  * E-mail: eahsan.rasul@ki.se

  Affiliation Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Instititet, Stockholm, Sweden

  ⨯
• Daniel Salamon,

  Affiliation Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Instititet, Stockholm, Sweden

  ⨯
• Noemi Nagy,

  Affiliation Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Instititet, Stockholm, Sweden

  ⨯
• Benjamin Leveau,

  Affiliation Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Instititet, Stockholm, Sweden

  ⨯
• Ferenc Banati,

  Affiliation RT-Europe Nonprofit Research Ltd, Mosonmagyaróvár, Hungary

  ⨯
• Kalman Szenthe,

  Affiliation RT-Europe Nonprofit Research Ltd, Mosonmagyaróvár, Hungary

  ⨯
• Anita Koroknai,

  Affiliation Microbiological Research Group, National Center for Epidemiology, Budapest, Hungary

  ⨯
• Janos Minarovits,

  Affiliations Microbiological Research Group, National Center for Epidemiology, Budapest, Hungary, University of Szeged, Faculty of Dentistry, Department of Oral Biology and Experimental Dental Research, Szeged, Hungary

  ⨯
• George Klein,

  Affiliation Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Instititet, Stockholm, Sweden

  ⨯
• Eva Klein

  Affiliation Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Instititet, Stockholm, Sweden

  ⨯